Treatment.com AI Inc. (CSE:TRUE)
Canada flag Canada · Delayed Price · Currency is CAD
0.4450
-0.0200 (-4.30%)
Mar 28, 2025, 3:51 PM EST

Treatment.com AI Statistics

Total Valuation

CSE:TRUE has a market cap or net worth of CAD 24.88 million. The enterprise value is 23.13 million.

Market Cap 24.88M
Enterprise Value 23.13M

Important Dates

The next estimated earnings date is Tuesday, April 29, 2025.

Earnings Date Apr 29, 2025
Ex-Dividend Date n/a

Share Statistics

CSE:TRUE has 57.85 million shares outstanding.

Current Share Class n/a
Shares Outstanding 57.85M
Shares Change (YoY) n/a
Shares Change (QoQ) +437.87%
Owned by Insiders (%) 8.43%
Owned by Institutions (%) n/a
Float 52.87M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 134.50
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -11.51
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.61

Current Ratio 0.61
Quick Ratio 0.54
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -21.70

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -221.31%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 291.26%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.07
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -25.83% in the last 52 weeks. The beta is -0.64, so CSE:TRUE's price volatility has been lower than the market average.

Beta (5Y) -0.64
52-Week Price Change -25.83%
50-Day Moving Average 0.54
200-Day Moving Average 0.65
Relative Strength Index (RSI) 43.80
Average Volume (20 Days) 92,378

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, CSE:TRUE had revenue of CAD 38,136 and -2.01 million in losses. Loss per share was -0.17.

Revenue 38,136
Gross Profit 24,190
Operating Income -1.94M
Pretax Income -2.01M
Net Income -2.01M
EBITDA n/a
EBIT -1.94M
Loss Per Share -0.17
Full Income Statement

Balance Sheet

The company has 897,393 in cash and 609,171 in debt, giving a net cash position of 288,222 or 0.00 per share.

Cash & Cash Equivalents 897,393
Total Debt 609,171
Net Cash 288,222
Net Cash Per Share 0.00
Equity (Book Value) -665,178
Book Value Per Share -0.02
Working Capital -665,178
Full Balance Sheet

Cash Flow

Operating Cash Flow -199,965
Capital Expenditures n/a
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross Margin 63.43%
Operating Margin -5,080.20%
Pretax Margin -5,268.63%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CSE:TRUE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -78.95%
Shareholder Yield -78.95%
Earnings Yield -8.08%
FCF Yield n/a

Stock Splits

The last stock split was on July 14, 2023. It was a reverse split with a ratio of 0.1.

Last Split Date Jul 14, 2023
Split Type Reverse
Split Ratio 0.1

Scores

CSE:TRUE has an Altman Z-Score of -39.52. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -39.52
Piotroski F-Score n/a